[Congressional Record (Bound Edition), Volume 157 (2011), Part 14]
[Extensions of Remarks]
[Pages 19178-19179]
[From the U.S. Government Publishing Office, www.gpo.gov]




                 A TRIBUTE TO DR. R. SANDLIN LOWE, III

                                 ______
                                 

                          HON. EDOLPHUS TOWNS

                              of new york

                    in the house of representatives

                      Wednesday, December 7, 2011

  Mr. TOWNS. Mr. Speaker, I rise today to honor Dr. R. Sandlin Lowe, 
III, MD for his outstanding contribution to Neuroscience and the 
treatment of brain disorders and injuries.
  Originally from Coosa County, Alabama, Dr. Lowe obtained his MD from 
Tulane University in 1987. Currently on the Faculty of New York 
University School of Medicine with appointments in both the Department 
of Psychiatry and the Department of Physiology and Neuroscience, he is 
the Consulting Neuropsychiatrist to the NYU School of Medicine Brain 
Research Laboratories and Collaborating Psychiatrist at the NYU Langone 
Center for Neuromagnetism. After 18 years of service and research (for 
which he was honored with a Congressional Award), Dr. Lowe has become a 
member of various research councils and health centers.
  Dr. Lowe is an expert in Translational Clinical Neuroscience and 
Therapeutics and has created new paradigms for the

[[Page 19179]]

conceptualization, evaluation, and treatment of consciousness spectrum 
disorders associated with brain injuries. In the past few years, for 
personal reasons, his efforts have focused on autism spectrum 
disorders.
  Currently, Dr. Lowe and his colleagues are exploring small molecules, 
biological, cellular and regenerative medicine therapeutics, and 
applied field energy techniques to find new treatments for autism and 
brain injuries.
  Dr. Lowe is a co-founder of the Global Alliance for Innovation in 
Neuroscience, to which he brings his experience and ability to 
creatively approach the study and management of coma and other brain 
injuries. Dr. Lowe possesses a remarkable energy with an unparalleled 
faith and optimism that are apparent in his approach to research and 
his dedication to patient care.
  Dr. Lowe has recently been awarded a grant of over $3.2 million from 
the Marcus foundation to study the safety and efficacy of cellular and 
regenerative medicine therapeutics in the treatment of autism. This 
work will be done by the GAIN labs at New York City Health and 
Hospitals Corporation in collaboration with the Stem Cell Institute in 
Panama, along with Inverion Technologies, Ltd. and Xplora Interactive 
India. Preliminary data from the individuals with autism who have 
received these treatments shows that these new methods are both safe 
and promising.
  Mr. Speaker, I would like to recognize Dr. R. Sandlin Lowe, III, MD 
for the advancements he has made in the study and treatment of autism 
spectrum disorders, brain injuries, and other disorders.

                          ____________________